These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7747920)
41. Challenges and Perspectives for Future Considerations in the Bioengineering of a Bioartificial Pancreas. Opara A; Canning P; Alwan A; Opara EC Ann Biomed Eng; 2024 Jul; 52(7):1795-1803. PubMed ID: 36913086 [TBL] [Abstract][Full Text] [Related]
42. Towards gene therapy of diabetes mellitus. Levine F; Leibowitz G Mol Med Today; 1999 Apr; 5(4):165-71. PubMed ID: 10203749 [TBL] [Abstract][Full Text] [Related]
43. Is there a possibility of a bioartificial pancreas? Reach G Biomater Artif Cells Artif Organs; 1990; 18(4):483-90. PubMed ID: 2285810 [No Abstract] [Full Text] [Related]
44. Progress in the treatment of diabetes type 1 and 2. Wasikowa RB; Basiak A Pediatr Endocrinol Diabetes Metab; 2007; 13(1):47-51. PubMed ID: 17493407 [TBL] [Abstract][Full Text] [Related]
45. Bioengineering aspects of the artificial pancreas. Nałecz M; Lewandowski J; Weryński A; Zawicki I Artif Organs; 1978 Aug; 2(3):305-9. PubMed ID: 568464 [TBL] [Abstract][Full Text] [Related]
47. Development of an artificial pancreas: the race is on. Elliott J JAMA; 1979 Jan; 241(3):223-5. PubMed ID: 758519 [No Abstract] [Full Text] [Related]
48. Multifaceted therapeutic approaches for a multigenic disease. Bottino R; Trucco M Diabetes; 2005 Dec; 54 Suppl 2():S79-86. PubMed ID: 16306345 [TBL] [Abstract][Full Text] [Related]
49. Role of artificial pancreas in juvenile diabetes. Rosenbloom AL J Pediatr; 1978 Apr; 92(4):689-91. PubMed ID: 633046 [No Abstract] [Full Text] [Related]
50. When your diabetic patient has a pancreas transplant. Zehrer J; Rode S Nursing; 1988 Mar; 18(3):108-9. PubMed ID: 3127760 [No Abstract] [Full Text] [Related]
51. Cell based therapeutics in type 1 diabetes mellitus. Zamboni F; Collins MN Int J Pharm; 2017 Apr; 521(1-2):346-356. PubMed ID: 28242376 [TBL] [Abstract][Full Text] [Related]
53. Recent advances in continuous glucose monitoring: biocompatibility of glucose sensors for implantation in subcutis. Kvist PH; Jensen HE J Diabetes Sci Technol; 2007 Sep; 1(5):746-52. PubMed ID: 19885143 [TBL] [Abstract][Full Text] [Related]
54. [The artificial pancreas, a dream on the point of becoming reality]. Renard É; Place J; Benbrahim N; Diouri O; Farret A Rev Infirm; 2017 Apr; 66(230):35-37. PubMed ID: 28366258 [TBL] [Abstract][Full Text] [Related]
55. Prototype glucose-oxygen sensor for the artificial pancreas. Bessman SP; Schultz RD Trans Am Soc Artif Intern Organs; 1973; 19():361-4. PubMed ID: 4722752 [No Abstract] [Full Text] [Related]
56. Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy. Webber MJ; Anderson DG; Langer R Expert Rev Endocrinol Metab; 2015; 10(5):483-489. PubMed ID: 27570535 [TBL] [Abstract][Full Text] [Related]
57. Artificial cells and bioencapsulation in bioartificial organs. Chang TM Ann N Y Acad Sci; 1997 Dec; 831():249-59. PubMed ID: 9616717 [TBL] [Abstract][Full Text] [Related]
58. Comparison of algorithms for the closed-loop control of blood glucose using the artificial beta cell. Broekhuyse HM; Nelson JD; Zinman B; Albisser AM IEEE Trans Biomed Eng; 1981 Oct; 28(10):678-87. PubMed ID: 7033107 [No Abstract] [Full Text] [Related]
59. [PROTIS, an expert system applied to the treatment of non-insulin-dependent diabetes. Evaluation of its efficacy]. Vialettes B; Soula G; Thirion X; San Marco JL; Roux M Presse Med; 1985 Nov; 14(41):2085-8. PubMed ID: 2934706 [TBL] [Abstract][Full Text] [Related]
60. Bioartificial organs. Risks and requirements. Hunkeler D Ann N Y Acad Sci; 1999 Jun; 875():1-6. PubMed ID: 10415553 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]